OTC Proposals Need To Protect End-Users Better

Proposals to regulate over-the-counter derivatives do not go far enough in exempting corporate OTC end-users from margining or capital provisions, according to Jiro Okochi, ceo and co-founder of Reval, a derivative risk management provider.